Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion

Molecular Biology of the Cell

Volumn 24, Issue 20, 2013, Pages 3164-3176

  Lopez Mejia, Isabel Cristina ^a,b   De Toledo, Marion ^a   Della Seta, Flavio ^a   Fafet, Patrick ^a   Rebouissou, Cosette ^a   Deleuze, Virginie ^a   Blanchard, Jean Marie ^a   Jorgensen, Christian ^c,d   Tazi, Jamal ^a   Vignais, Marie Luce ^a,c  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c HÔPITAL SAINT ELOI   (France)

^d LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; PROTEIN; PROTEIN SRSF1; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; COCULTURE; DERMIS; ENDOMETRIUM; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TISSUE SPECIFICITY; TROPHOBLAST;

ABORTION, INDUCED; ALTERNATIVE SPLICING; ENDOMETRIUM; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PLACENTA; PREGNANCY; PRIMARY CELL CULTURE; RNA-BINDING PROTEINS; TROPHOBLASTS;

EID: 84885640870     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-03-0142     Document Type: Article

References (69)

1. Abe Y, Bui-Thanh NA, Ballantyne CM, Burns AR (2005). Extra domain A and type III connecting segment of fibronectin in assembly and cleavage. Biochem Biophys Res Commun 338, 1640-1647.
2. Al-Ayoubi AM, Zheng H, Liu Y, Bai T, Eblen ST (2012). Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion. Mol Cell Biol 32, 2880-2893.
3. Aplin JD, Haigh T, Jones CJ, Church HJ, Vicovac L (1999). Development of cytotrophoblast columns from explanted first-trimester human placental villi: role of fibronectin and integrin alpha5beta1. Biol Reprod 60, 828-838.
4. Astrof S, Crowley D, Hynes RO (2007). Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol 311, 11-24.
5. Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, Blencowe BJ, Frey BJ (2010). Deciphering the splicing code. Nature 465, 53-59.
6. Barkan D, Green JE, Chambers AF (2010). Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 46, 1181-1188.
7. Bischof P, Haenggeli L, Campana A (1995). Gelatinase and oncofetal fibronectin secretion is dependent on integrin expression on human cytotrophoblasts. Hum Reprod 10, 734-742.
8. Blaustein M et al. (2005). Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 12, 1037-1044.
9. Blaustein M, Quadrana L, Risso G, Mata Mde L, Pelisch F, Srebrow A (2009). SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms. J Cell Biochem 107, 826-833.
10. Buratti E, Baralle FE (2004). Influence of RNA secondary structure on the pre-mRNA splicing process. Mol Cell Biol 24, 10505-10514.
11. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO (2002). Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 99, 12877-12882.
12. Chen M, Manley JL (2009). Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 10, 741-754.
13. Cramer P, Caceres JF, Cazalla D, Kadener S, Muro AF, Baralle FE, Kornblihtt AR (1999). Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell 4, 251-258.
14. Cramer P, Pesce CG, Baralle FE, Kornblihtt AR (1997). Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci USA 94, 11456-11460.
15. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ (1994). Integrin switching regulates normal trophoblast invasion. Development 120, 3657-3666.
16. de la Mata M, Alonso CR, Kadener S, Fededa JP, Blaustein M, Pelisch F, Cramer P, Bentley D, Kornblihtt AR (2003). A slow RNA polymerase II affects alternative splicing in vivo. Mol Cell 12, 525-532.
17. de la Mata M, Lafaille C, Kornblihtt AR (2010). First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal. RNA 16, 904-912.
18. Fafet P, Rebouissou C, Maudelonde T, Vignais ML (2008). Opposite effects of transforming growth factor-beta activation and rho-associated kinase inhibition on human trophoblast migration in a reconstituted placental-endometrial coculture system. Endocrinology 149, 4475-4485.
19. Feinberg RF, Kliman HJ, Lockwood CJ (1991). Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol 138, 537-543.
20. Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO (1989). Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109, 903-914.
21. Frantz C, Stewart KM, Weaver VM (2010). The extracellular matrix at a glance. J Cell Sci 123, 4195-4200.
22. Friedl P, Alexander S (2011). Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009.
23. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079-1091.
24. Guan JL, Trevithick JE, Hynes RO (1990). Retroviral expression of alternatively spliced forms of rat fibronectin. J Cell Biol 110, 833-847.
25. Harris LK, Jones CJ, Aplin JD (2009). Adhesion molecules in human trophoblast-a review. [II] Extravillous trophoblast. Placenta 30, 299-304.
26. Hartmann B, Valcarcel J (2009). Decrypting the genome's alternative messages. Curr Opin Cell Biol 21, 377-386.
27. Heino J (2007). The collagen family members as cell adhesion proteins. Bioessays 29, 1001-1010.
28. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD (2003). Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302, 2141-2144.
29. Joyce JA, Pollard JW (2009). Microenvironmental regulation of metastasis. Nat Rev Cancer 9, 239-252.
30. Kadener S, Cramer P, Nogues G, Cazalla D, de la Mata M, Fededa JP, Werbajh SE, Srebrow A, Kornblihtt AR (2001). Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing. EMBO J 20, 5759-5768.
31. Kadener S, Fededa JP, Rosbash M, Kornblihtt AR (2002). Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation. Proc Natl Acad Sci USA 99, 8185-8190.
32. Kadler KE, Hill A, Canty-Laird EG (2008). Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 20, 495-501.
33. Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR (2007). The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14, 185-193.
34. Kuo BA, Uporova TM, Liang H, Bennett VD, Tuan RS, Norton PA (2002). Alternative splicing during chondrogenesis: modulation of fibronectin exon EIIIA splicing by SR proteins. J Cell Biochem 86, 45-55.
35. Leiss M, Beckmann K, Giros A, Costell M, Fassler R (2008). The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr Opin Cell Biol 20, 502-507.
36. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T (2011). Epigenetics in alternative pre-mRNA splicing. Cell 144, 16-26.
37. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T (2010). Regulation of alternative splicing by histone modifications. Science 327, 996-1000.
38. Lu P, Weaver VM, Werb Z (2012). The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196, 395-406.
39. Manabe R, Ohe N, Maeda T, Fukuda T, Sekiguchi K (1997). Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol 139, 295-307.
40. Mao Y, Schwarzbauer JE (2005). Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24, 389-399.
41. McKeown-Longo PJ, Etzler CA (1987). Induction of fibronectin matrix assembly in human fibrosarcoma cells by dexamethasone. J Cell Biol 104, 601-610.
42. Mermoud JE, Cohen PT, Lamond AI (1994). Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J 13, 5679-5688.
43. Misteli T, Caceres JF, Clement JQ, Krainer AR, Wilkinson MF, Spector DL (1998). Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J Cell Biol 143, 297-307.
44. Misteli T, Caceres JF, Spector DL (1997). The dynamics of a pre-mRNA splicing factor in living cells. Nature 387, 523-527.
45. Moretti FA, Chauhan AK, Iaconcig A, Porro F, Baralle FE, Muro AF (2007). A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived. J Biol Chem 282, 28057-28062.
46. Munoz MJ, de la Mata M, Kornblihtt AR (2010). The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends Biochem Sci 35, 497-504.
47. Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, Baralle FE (2003). Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 162, 149-160.
48. Nguyen DX, Bos PD, Massague J (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9, 274-284.
49. Nogues G, Kadener S, Cramer P, Bentley D, Kornblihtt AR (2002). Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem 277, 43110-43114.
50. Nogués G, Muñoz MJ, Kornblihtt AR (2003). Influence of polymerase II processivity on alternative splicing depends on splice site strength. J Biol Chem 278, 52166-52171.
51. Norwitz ER, Schust DJ, Fisher SJ (2001). Implantation and the survival of early pregnancy. N Engl J Med 345, 1400-1408.
52. Paget S (1889). The distribution of secondary growths in cancer of the breast. Lancet 1, 571-573.
53. Pankov R, Yamada KM (2004). Non-radioactive quantification of fibronectin matrix assembly. Curr Protoc Cell Biol, Chapter 10, Unit 10.13.
54. Peters DM, Portz LM, Fullenwider J, Mosher DF (1990). Co-assembly of plasma and cellular fibronectins into fibrils in human fibroblast cultures. J Cell Biol 111, 249-256.
55. Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY (2006). Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet 2, e119.
56. Rybak JN, Roesli C, Kaspar M, Villa A, Neri D (2007). The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 67, 10948-10957.
57. Sen S, Talukdar I, Webster NJ (2009). SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing. Mol Cell Biol 29, 871-880.
58. Singh P, Carraher C, Schwarzbauer JE (2010). Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26, 397-419.
59. Sinha R, Allemand E, Zhang Z, Karni R, Myers MP, Krainer AR (2010). Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF. Mol Cell Biol 30, 2762-2774.
60. Sottile J, Shi F, Rublyevska I, Chiang HY, Lust J, Chandler J (2007). Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin. Am J Physiol Cell Physiol 293, C1934-C1946.
61. Soundararajan R, Rao AJ (2004). Trophoblast "pseudo- tumorigenesis": significance and contributory factors. Reprod Biol Endocrinol 2, 15.
62. Sun S, Zhang Z, Sinha R, Karni R, Krainer AR (2010). SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control. Nat Struct Mol Biol 17, 306-312.
63. Valacca C, Bonomi S, Buratti E, Pedrotti S, Baralle FE, Sette C, Ghigna C, Biamonti G (2010). Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol 191, 87-99.
64. Venables JP et al. (2013). RBFOX2 is an important regulator of mesenchymal-specific splicing in both normal and cancer tissues. Mol Cell Biol 33, 396-405.
65. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008). Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476.
66. White ES, Baralle FE, Muro AF (2008). New insights into form and function of fibronectin splice variants. J Pathol 216, 1-14.
67. White ES et al. (2010). Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway. Exp Cell Res 316, 2644-2653.
68. Zahler AM, Neugebauer KM, Stolk JA, Roth MB (1993). Human SR proteins and isolation of a cDNA encoding SRp75. Mol Cell Biol 13, 4023-4028.
69. Zoppi N, Ritelli M, Colombi M (2012). Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts. Biochim Biophys Acta 1820, 1576-1587.